The earnings call highlights several concerns: a significant decline in procedure revenue, gross profit margin, net income, and adjusted EBITDA. The recall and supply constraints have negatively impacted performance, with ongoing issues expected to affect Q2. Although management expresses confidence in future growth, the lack of specific metrics and continued inventory issues raise doubts. The Q&A session reveals analyst concerns about stabilization and supply constraints. Despite some positive signs, the overall sentiment is negative due to financial declines and uncertainties.